Dr Helen Campbell
Helen Campbell
BA MSc DPhil
Researcher in Health Economics
Helen joined the National Perinatal Epidemiology Unit (NPEU) as a health economics researcher in August 2015, currently involved in a number of modelling projects looking at the cost-effectiveness of controlling gestational weight gain in obese pregnant women and the cost-effectiveness of first trimester antenatal anomaly screening.
Helen has experience of trial and model-based health economic evaluation as well as costing studies. She has previously worked on projects estimating the costs of stillbirth and looking at the longer-term costs and health outcomes of children surviving perinatal asphyxia.
She has worked for 13 years as an economist at the Health Economics Research Centre, which is also based within the University of Oxford. Helen has an MSc in Health Economics from the University of York, and a DPhil in Health Economics which was awarded by the University of Oxford in 2008.
Recent publications
-
Evaluating the Cost-Effectiveness of Antenatal Screening for Major Structural Anomalies During the First Trimester of Pregnancy: A Decision Model.
Journal article
Campbell HE. et al, (2025), BJOG
-
Improving outcomes for very preterm babies in England: does place of birth matter? Findings from OPTI-PREM, a national cohort study.
Journal article
Pillay T. et al, (2024), Arch Dis Child Fetal Neonatal Ed
-
Frameworks for modelling the potential longer-term costs and consequences of self-monitoring of blood pressure (SMBP) during pregnancy
Report
CAMPBELL H. et al, (2024)
-
Exploring the potential cost-effectiveness of a new computerised decision support tool for identifying fetal compromise during monitored term labours: an early health economic model.
Journal article
CAMPBELL H. et al, (2024), Cost Effectiveness and Resource Allocation
-
Detection and control of pregnancy hypertension using self-monitoring of blood pressure with automated telmonitoring: cost analyses of the BUMP randomised trials
Journal article
RIVERO ARIAS O. et al, (2024), Hypertension